Morgan Stanley Senseonics Holdings, Inc. Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Morgan Stanley holds 271,629 shares of SENS stock, worth $260,763. This represents 0.0% of its overall portfolio holdings.
Number of Shares
271,629
Previous 404,954
32.92%
Holding current value
$260,763
Previous $141,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding SENS
# of Institutions
138Shares Held
80.6MCall Options Held
418KPut Options Held
219K-
Vanguard Group Inc Valley Forge, PA22.2MShares$21.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.32MShares$7.99 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA7MShares$6.72 Million0.14% of portfolio
-
First Light Asset Management, LLC Edina, MN6.43MShares$6.17 Million0.33% of portfolio
-
Geode Capital Management, LLC Boston, MA6.41MShares$6.15 Million0.0% of portfolio
About Senseonics Holdings, Inc.
- Ticker SENS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 465,447,008
- Market Cap $447M
- Description
- Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...